Literature DB >> 17268522

Risk factors of central venous lines-related thrombosis in children with acute lymphoblastic leukemia during induction therapy: a prospective study.

L Farinasso, N Bertorello, L Garbarini, T M Gajno, E Barisone, L Artesani, A Valori, M Giacchino, G Pastore, P Saracco.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17268522     DOI： 10.1038/sj.leu.2404560

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  9 in total

1.  Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study.

Authors:  Lesley Mitchell; Moritz Lambers; Silke Flege; Gili Kenet; Valerie Li-Thiao-Te; Susanne Holzhauer; Christoph Bidlingmaier; Michael C Frühwald; Christine Heller; Wolfgang Schmidt; Brigitte Pautard; Ulrike Nowak-Göttl
Journal:  Blood       Date:  2010-03-25       Impact factor: 22.113

2.  A prospective 7-year survey on central venous catheter-related complications at a single pediatric hospital.

Authors:  M Pinon; S Bezzio; P A Tovo; F Fagioli; L Farinasso; R Calabrese; M Marengo; M Giacchino
Journal:  Eur J Pediatr       Date:  2009-03-17       Impact factor: 3.183

3.  Epidemiology and outcomes of clinically unsuspected venous thromboembolism in children: A systematic review.

Authors:  Anjali A Sharathkumar; Tina Biss; Ketan Kulkarni; Sanjay Ahuja; Matt Regan; Christoph Male; Shoshana Revel-Vilk
Journal:  J Thromb Haemost       Date:  2020-04-15       Impact factor: 5.824

Review 4.  Association of thrombophilia and catheter-associated thrombosis in children: a systematic review and meta-analysis.

Authors:  S Neshat-Vahid; R Pierce; D Hersey; L J Raffini; E V S Faustino
Journal:  J Thromb Haemost       Date:  2016-07-29       Impact factor: 5.824

5.  Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years.

Authors:  Cecilie Utke Rank; Nina Toft; Ruta Tuckuviene; Kathrine Grell; Ove Juul Nielsen; Thomas Leth Frandsen; Hanne Vibeke Hansen Marquart; Birgitte Klug Albertsen; Ulf Tedgård; Helene Hallböök; Ellen Ruud; Kirsten Brunsvig Jarvis; Petter Quist-Paulsen; Pasi Huttunen; Ulla Wartiovaara-Kautto; Ólafur Gísli Jónsson; Sonata Saulyte Trakymiene; Laimonas Griškevičius; Kadri Saks; Mari Punab; Kjeld Schmiegelow
Journal:  Blood       Date:  2018-04-16       Impact factor: 22.113

6.  Quantifying the difference in risk of adverse events by induction treatment regimen in pediatric acute lymphoblastic leukemia.

Authors:  Zachary E West; Sharon M Castellino; Caitlin Monroe; Amanda S Thomas; Courtney McCracken; Tamara P Miller
Journal:  Leuk Lymphoma       Date:  2020-12-01

Review 7.  Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy.

Authors:  Kjeld Schmiegelow; Klaus Müller; Signe Sloth Mogensen; Pernille Rudebeck Mogensen; Benjamin Ole Wolthers; Ulrik Kristoffer Stoltze; Ruta Tuckuviene; Thomas Frandsen
Journal:  F1000Res       Date:  2017-04-07

Review 8.  Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open-Cancer Horizons roundtable discussion.

Authors:  Patrick W Burke; Dieter Hoelzer; Jae H Park; Kjeld Schmiegelow; Dan Douer
Journal:  ESMO Open       Date:  2020-10

Review 9.  Management of venous thrombosis in the pediatric patient.

Authors:  Vlad C Radulescu
Journal:  Pediatric Health Med Ther       Date:  2015-07-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.